Phase II study of novel CXCR2 agonist and Plerixafor for rapid stem cell mobilization in patients with multiple myeloma
一项针对多发性骨髓瘤患者的新型CXCR2激动剂和普乐沙福快速动员干细胞的II期研究
期刊:Blood Cancer Journal
影响因子:11.6
doi:10.1038/s41408-024-01152-1
Sidana, Surbhi; Bankova, Andriyana K; Hosoya, Hitomi; Kumar, Shaji K; Holmes, Tyson H; Tamaresis, John; Le, Anne; Muffly, Lori S; Maysel-Auslender, Sofia; Johnston, Laura; Arai, Sally; Lowsky, Robert; Meyer, Everett; Rezvani, Andrew; Weng, Wen-Kai; Frank, Matthew J; Shiraz, Parveen; Maecker, Holden T; Lu, Ying; Miklos, David B; Shizuru, Judith A
CR2
发育与干细胞
多发性骨髓瘤
骨髓瘤
CXCR2
干细胞
细胞生物学